Earnings History Data for Verastem (VSTM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Verastem
Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company's defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | PM | VSTM | Verastem | 157.00 | -0.60 | -0.71 | 0.00 | Verastem GAAP EPS of -$0.60 beats by $0.14 [11/7/2024 2:34 AM] |
3.62 | -0.25 (-6.59%) |
3.75 | -0.12 (-3.10%) |
2.10 - 14.22 | 693,300 | 820,000 | 30,283 | ||
| 08-08-2024 | AH | VSTM | Verastem | 59.00 | -0.31 | -1.06 | 0.00 | Verastem Non-GAAP EPS of -$0.61 beats by $0.45 [8/8/2024 5:52 PM] |
2.37 | 0.12 (5.58%) |
2.40 | 0.16 (7.14%) |
2.10 - 14.22 | 254,259 | 730,000 | 2,994 | ||
| 09-05-2024 | AH | VSTM | Verastem | 289.00 | -1.26 | -1.16 | 0.00 | Verastem GAAP EPS of -$1.26 [5/9/2024 5:23 PM] |
11.82 | -0.10 (-0.84%) |
11.92 | 0.0 (0.00%) |
4.68 - 15.18 | 71,081 | 100,000 | 143 | ||
| 14-03-2024 | AH | VSTM | Verastem | 274.00 | -1.02 | -0.82 | 0.00 | Verastem GAAP EPS of -$1.02 misses by $0.21 [3/14/2024 5:16 PM] |
11.00 | 0.50 (4.76%) |
10.20 | -0.30 (-2.86%) |
4.20 - 15.18 | 159,743 | 150,000 | 320 | ||
| 08-11-2023 | AH | VSTM | Verastem | 167.00 | -0.75 | -0.92 | 0.00 | Verastem Non-GAAP EPS of -$0.71 beats by $0.08 [11/8/2023 5:20 PM] |
6.60 | -0.47 (-6.65%) |
7.06 | -0.01 (-0.14%) |
3.87 - 15.18 | 72,643 | 70,000 | 417 | ||
| 08-08-2023 | AH | VSTM | Verastem | 187.00 | -1.37 | -1.13 | 0.00 | Verastem Non-GAAP EPS of -$1.06 misses by $0.04 [8/8/2023 5:27 PM] |
9.98 | -0.05 (-0.50%) |
0.0 | 0.0 (0.00%) |
3.47 - 17.52 | 151,981 | 200,000 | 0 | ||
| 09-05-2022 | AH | After the close (May 9) |
VSTM | Verastem | 250.00 | -0.09 | -0.08 | 0.00 | Verastem Non-GAAP EPS of -$0.08 beats by $0.01, revenue of $2.6M beats by $1.1M [5/9/2022 5:12 PM] |
1.20 | 0.06 (5.70%) |
1.14 | 0.0 (0.00%) |
1.04 - 4.93 | 1,410,416 | 2,293,886 | 2,239 | |
|
||||||||||||||||||
| 28-03-2022 | PM | VSTM | Verastem | 224.00 | -0.09 | -0.08 | 0.00 | Verastem Non-GAAP EPS of -$0.08 beats by $0.04, revenue of $0.51M [3/28/2022 7:58 AM] |
1.32 | 0.13 (10.92%) |
1.32 | 0.0 (0.00%) |
1.04 - 4.93 | 1,804,040 | 3,130,000 | 49,605 | ||
|
||||||||||||||||||
| 02-08-2021 | AH | 4:05 PM ET (Aug 2) |
VSTM | Verastem, Inc. | 571.00 | -0.10 | -0.09 | 0.00 | Verastem EPS misses by $0.02, beats on revenue [8/2/2021 4:41 PM] |
2.89 | -0.31 (-9.81%) |
3.18 | -0.03 (-0.93%) |
1.08 - 4.93 | 3,362,490 | 1,040,000 | 2,756 | |
| 11-05-2021 | AH | 4:05 PM ET (May 11) |
VSTM | Verastem, Inc. | 489.00 | -0.09 | -0.09 | 0.00 | Verastem EPS in-line [5/11/2021 4:29 PM] |
2.79 | -0.19 (-6.54%) |
3.00 | 0.02 (0.67%) |
1.08 - 3.20 | 1,741,769 | 2,680,000 | 1,925 | |
| 18-03-2021 | AH | 4:05 PM ET (Mar 18) |
VSTM | Verastem, Inc. | 400.67 | -0.12 | 0.00 | -0.51 | Verastem EPS in-line, misses on revenue [3/18/2021 4:27 PM] |
2.41 | 0.05 (1.90%) |
2.40 | 0.03 (1.27%) |
1.08 - 4.67 | 2,612,582 | 1,910,000 | 50,895 | |
| 09-11-2020 | AH | After the close (Nov 9) |
VSTM | Verastem, Inc. | 217.00 | 0.08 | 0.28 | -0.35 | Verastem EPS beats by $0.04, beats on revenue [11/9/2020 4:43 PM] |
1.42 | 0.12 (8.78%) |
1.28 | -0.03 (-2.29%) |
0.83 - 4.67 | 5,376,564 | 2,839,487 | 18,432 | |
|
|
||||||||||||||||||